BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
57.18
-1.26 (-2.16%)
At close: Oct 2, 2026, 4:00 PM EDT
57.34
+0.16 (0.28%)
After-hours: Oct 2, 2026, 7:30 PM EDT
BioMarin Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $86 | Buy | Maintains | $86 | +50.40% | Sep 21, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $86 | Buy | Maintains | $86 | +50.40% | Sep 18, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $124 | Buy | Reiterates | $124 | +116.86% | Sep 16, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $98 → $97 | Buy | Reiterates | $98 → $97 | +69.64% | Sep 15, 2026 |
| Citi | Citi | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $80 | Buy | Maintains | $80 | +39.91% | Sep 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $60 | Hold | Reiterates | $60 | +4.93% | Sep 10, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $70 | Hold | Maintains | $70 | +22.42% | Sep 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.